Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Apr;62(4):316-21.
doi: 10.1136/ard.62.4.316.

Number needed to treat (NNT): implication in rheumatology clinical practice

M Osiri  1 , M E Suarez-Almazor, G A Wells, V Robinson, P Tugwell
Affiliations

Number needed to treat (NNT): implication in rheumatology clinical practice

M Osiri et al. Ann Rheum Dis. 2003 Apr.

Abstract

Objective: To calculate the number needed to treat (NNT) and number needed to harm (NNH) from the data in rheumatology clinical trials and systematic reviews.

Methods: The NNTs for the clinically important outcome measures in the rheumatology systematic reviews from the Cochrane Library, issue 2, 2000 and in the original randomised, double blind, controlled trials were calculated. The measure used for calculating the NNT in rheumatoid arthritis (RA) interventions was the American College of Rheumatology 20% improvement or Paulus criteria; in osteoarthritis (OA) interventions, the improvement of pain; and in systemic sclerosis (SSc) interventions, the improvement of Raynaud's phenomenon. The NNH was calculated from the rate of withdrawals due to adverse events from the treatment.

Results: The data required for the calculation of the NNT were available in 15 systematic reviews and 11 original articles. For RA interventions, etanercept treatment for six months had the smallest NNT (1.6; 95% confidence interval (CI) 1.4 to 2.0), whereas leflunomide had the largest NNH (9.6; 95% CI 6.8 to 16.7). For OA treatment options, only etodolac and tenoxicam produced significant pain relief compared with placebo (NNT=4.4; 95% CI 2.4 to 24.4 and 3.8; 95% CI 2.5 to 7.3, respectively). For SSc interventions, none were shown to be efficacious in improving Raynaud's phenomenon because the 95% CI of the NNT was infinite.

Conclusions: The NNT and NNH are helpful for clinicians, enabling them to translate the results from clinical trials and systematic reviews to use in routine clinical practice. Both NNT and NNH should be accompanied by a limited 95% CI and adjusted for the individual subject's baseline risk.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Number needed to treat (NNT) and number needed to harm (NNH) in RA clinical trials and systematic reviews. *95% CI not calculated for non-significant results. SSZ, sulfasalazine; MTX, methotrexate; CYC, cyclophosphamide; AZA, azathioprine; D-Pen, D-penicillamine; CsA, cyclosporin A; Pred, prednisolone; TJC, tender joint count.
See this image and copyright information in PMC

References

    1. Arch Intern Med. 1999 Nov 22;159(21):2542-50 - PubMed
    1. Ann Intern Med. 1999 Mar 16;130(6):478-86 - PubMed
    1. Med Care. 2001 Oct;39(10):1039-47 - PubMed
    1. Arthritis Rheum. 1976 May-Jun;19(3):563-73 - PubMed
    1. Arthritis Rheum. 1983 May;26(5):581-92 - PubMed

MeSH terms

Substances